scispace - formally typeset
Journal ArticleDOI

Electronegative LDL induces priming and inflammasome activation leading to IL-1β release in human monocytes and macrophages

TLDR
LDL(−) promotes release of biologically active IL-1β in monocytes and MDM by induction of the two steps involved: priming and NLRP3 inflammasome activation.
About
This article is published in Biochimica et Biophysica Acta.The article was published on 2015-11-01. It has received 37 citations till now. The article focuses on the topics: Receptor complex.

read more

Citations
More filters
Journal ArticleDOI

Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities

TL;DR: In advanced atherosclerotic lesions, the ratio between specialized pro-resolving mediators and pro-inflammatory lipids is strikingly low, providing a molecular explanation for the defective inflammation resolution features of these lesions.
Journal ArticleDOI

L5-LDL from ST-elevation myocardial infarction patients induces IL-1β production via LOX-1 and NLRP3 inflammasome activation in macrophages

TL;DR: The results showed that L5-LDL induced activation of caspase-1 and NF-κB through the lectin-type oxidized LDL receptor (LOX-1)-dependent pathway, leading to the production of IL-1β.
Journal ArticleDOI

Lysophosphatidylcholine Induces NLRP3 Inflammasome-Mediated Foam Cell Formation and Pyroptosis in Human Monocytes and Endothelial Cells.

TL;DR: The results showed that LPC induced foam cell formation in both types of cells by increasing LD biogenesis via a NLRP3 inflammasome-dependent pathway and the IL-1β secretion and foamcell formation triggered by LPC via an inflammaome-mediated pathway in human monocytes and endothelial cells.
References
More filters
Journal ArticleDOI

Sterile inflammation: sensing and reacting to damage

TL;DR: The triggers and receptor pathways that result in sterile inflammation and its impact on human health are reviewed.
Journal ArticleDOI

Interleukin-1 and interleukin-1 antagonism.

TL;DR: The recent cloning of a naturally occurring IL-1 receptor antagonist (IL-1ra) has opened new experimental and clinical approaches and reduced the severity of diseases such as hemodynamic shock, lethal sepsis, inflammatory bowel disease, experimental arthritis, and the spontaneous proliferation of human leukemic cells.
Journal ArticleDOI

The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance

TL;DR: It is established that calorie restriction and exercise-mediated weight loss in obese individuals with type 2 diabetes is associated with a reduction in adipose tissue expression of Nlrp3 as well as with decreased inflammation and improved insulin sensitivity, and that the NlrP3 inflammasome senses obesity-associated danger signals and contributes to obesity-induced inflammation and insulin resistance.
Journal ArticleDOI

Interleukin-1 in the pathogenesis and treatment of inflammatory diseases

TL;DR: This review summarizes acute and chronic inflammatory diseases that are treated by reducing IL-1β activity and proposes that disease severity is affected by the anti-inflammatory members of the IL- 1 family of ligands and receptors.
Journal ArticleDOI

Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf.

TL;DR: Interestingly, cell death triggered by stimuli that engage caspase-1 was ablated in macrophages lacking either ASC or Ipaf, suggesting a coupling between the inflammatory and cell death pathways.
Related Papers (5)